CurifyLabs Raises $14M Series A to Advance Personalized Medicine Manufacturing
Health technology firm CurifyLabs has secured $14 million in Series A funding to enhance its supply chain, customer support, and R&D. The investment aims to advance personalized medicine production.
HELSINKI and JACKSONVILLE, Fla. – Health technology company CurifyLabs announced the closing of a $14 million Series A financing round. The investment was led by Sandwater, HealthCap, and Tesi.
The company stated on Tuesday that the capital raised will be used to strengthen its supply chain operations, customer support services, and research and development efforts in the manufacturing of personalized medicines.
CurifyLabs focuses on improving and scaling the production processes for specialized medications. This funding is expected to enable broader adoption of the company's technology and solidify its market standing.
As part of its growth strategy, CurifyLabs also intends to forge new partnerships within the pharmaceutical industry. The objective is to accelerate the advancement and availability of personalized medical treatments.